The Novo Nordisk Foundation, the Broad Institute of MIT and Harvard have launched an initiative to gain insights into disease mechanisms.
In an effort to accelerate efforts to mine genetic data for insights into mechanisms, and eventually rationally designed treatments, the trio of entities launched the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease based at the Broad Institute in Cambridge, Massachusetts.
Get the full story at our sister site, Drug Delivery Business News.
[Photo by Fusion Medical Animation on Unsplash]
The National Institutes of Health announced a $129.3 million plan to support scaling and manufacturing for COVID-19 tests.As part of its Rapid Acceleration of Diagnostics (RADx) initiative, NIH is awarding contracts to nine companies for their technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can produce results in 24 hours.
Yesterday’s announcement follows a July investment in seven companies from NIH worth $248.7 million in new technologies to address challenges with COVID-19 testing.
Some of the testing technologies are also being supported by the Biomedical Advanced Research and Development Authority (BARDA) as part of the U.S. Dept. of Health and Human Services, along with Defense Advanced Research Projects Agency (DARPA), in the U.S. Defense Dept.
Here are the nine co…